Rennova Health, Inc. (RNVA)

Rennova Health Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-93.49%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.12

Current Ratio	0.12
Quick Ratio	0.06
Debt / Equity	n/a
Debt / EBITDA	2.82
Debt / FCF	3.28
Interest Coverage	1.80

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	11.35%
Return on Capital (ROIC)	n/a
Revenue Per Employee	189,745
Profits Per Employee	22,010
Employee Count	107
Asset Turnover	1.01
Inventory Turnover	27.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	53.11
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	65.57
Average Volume (20 Days)	2,046,110

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rennova Health had revenue of 20.30 million and earned 2.36 million in profits.

Revenue	20.30M
Gross Profit	12.81M
Operating Income	3.65M
Pretax Income	3.01M
Net Income	2.36M
EBITDA	4.01M
EBIT	3.65M
Earnings Per Share (EPS)	-0.00

Balance Sheet

The company has 123,898 in cash and 12.24 million in debt, giving a net cash position of -12.11 million.

Cash & Cash Equivalents	123,898
Total Debt	12.24M
Net Cash	-12.11M
Net Cash Per Share	n/a
Equity (Book Value)	-27.57M
Book Value Per Share	-0.00
Working Capital	-41.51M

Cash Flow

In the last 12 months, operating cash flow was 4.05 million and capital expenditures -323,963, giving a free cash flow of 3.73 million.

Operating Cash Flow	4.05M
Capital Expenditures	-323,963
Free Cash Flow	3.73M
FCF Per Share	n/a

Margins

Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.60%.

Gross Margin	63.10%
Operating Margin	17.96%
Pretax Margin	14.83%
Profit Margin	11.60%
EBITDA Margin	19.77%
EBIT Margin	17.96%
FCF Margin	18.36%

Dividends & Yields

Rennova Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12,298.36%
Shareholder Yield	-12,298.36%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on March 16, 2022. It was a reverse split with a ratio of 0.0001.

Last Split Date	Mar 16, 2022
Split Type	Reverse
Split Ratio	0.0001

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a